The World Economic Forum annual meeting took place May 22-26, 2022, in Davos, Switzerland

The World Economic Forum’s annual meeting on May 22-26 convened business and government leaders to tackle some of the biggest global challenges, which right now include the economy, war in Ukraine, and the ongoing pandemic.
This article is part of the “Financing a Sustainable Future” series exploring how companies take steps to set and fund sustainable goals. 
The series includes an advisory council of industry leaders. Some of their CEOs took the stage in Davos to talk about issues pertinent to global prosperity, including health, education, and the durability of ESG promises. 

It was a WEF meeting like no other. 

“Davos 2022 was a meeting of many firsts,” read one of the World Economic Forum’s own summary of the proceedings. “Our first Annual Meeting in the Alpine spring, the first physical one since the outbreak of COVID-19, the first since the invasion of Ukraine, and the first meeting of global climate leaders since COP26.”

Amid the sessions analyzing the impact of the war in Eastern Europe, and fretting about the global economy, many of the content sessions focused on issues that relate directly to the Prosperity pillar of the Financing a Sustainable Future series.

Prosperity goals seek to help communities thrive, through adequate employment, access to healthcare, and education. 

Following is a look at some of what the CEOs of Pfizer, Bank of America, Infosys, and Deloitte, and their fellow panelists, had to say at WEF, on topics that are of critical importance to global communities. 

 

A new commitment to global health

Global pharmaceutical company Pfizer made the biggest news out of WEF, announcing its new “Accord for a Healthier World” initiative.

Pfizer will provide all its patented medicines and vaccines that are available in the US or the European Union on a not-for-profit basis to 1.2 billion people living in 45 lower-income countries,” said global CEO Pfizer CEO Albert Bourla, in a press conference. 

“This includes all 27 lower-income countries, as well as all 18 countries that have transitioned from low-income to lower-middle-income classification in the last 10 years.”

As Bourla said, supplying medication alone was not enough to resolve global health problems in countries that lack infrastructure, education, healthcare professionals, and diagnostic tools.

To try and fill those gaps, Pfizer will deploy resources in Rwanda, Malawi, Uganda, Ghana, and Senegal to try and optimize …read more

Source:: Business Insider

      

CEOs from Infosys, Deloitte, Pfizer, and Bank of America spoke about prosperity and ESG at the World Economic Forum

Leave a Reply

Your email address will not be published. Required fields are marked *